Metabolically designed for high cell yield and antibody production;
Complexed lipids for enhanced stability;
Support high cell density culture in bioreactors;
Allows for direct or sequential adaptation;
Optimized for Protein A, Protein G and other purification matrices;
Component traceability;
Manufactured under cGMP;
Increases the process yields for the industrial manufacture of human and humanized recombinant antibodies and antibody fragments for therapeutic use in a variety of engineered hybridoma and recombinant myeloma cell lines;
Low protein formulation and is optimized for downstream purification using Protein A, Protein G and other matrices to facilitate product recovery;
Developed for use with suspension cultures in high density bioreactors;